concept

CELLULAR SENESCENCE

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about CELLULAR SENESCENCE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

325Connections

2Hypotheses

8Analyses

50Outgoing

50Incoming

0Experiments

19Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	CELLULAR SENESCENCE

Pathway Diagram

graph TD
    CELLULAR_SENESCENCE["CELLULAR SENESCENCE"]
    style CELLULAR_SENESCENCE fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
    CELLULAR_SENESCENCE -->|"involved_in"| Cardiac_Aging["Cardiac Aging"]
    CELLULAR_SENESCENCE -->|"causes"| Cell_Cycle_Arrest(Cell Cycle Arrest)
    CELLULAR_SENESCENCE -->|"causes"| Apoptosis_Resistance(Apoptosis Resistance)
    CELLULAR_SENESCENCE -->|"causes"| Senescence_Associated_Secretor(Senescence-Associated Secretory Phenotype)
    CELLULAR_SENESCENCE -->|"causes"| cell_cycle_arrest(cell cycle arrest)
    CELLULAR_SENESCENCE -->|"promotes"| pro_inflammatory_molecules["pro-inflammatory molecules"]
    CELLULAR_SENESCENCE -->|"expressed in"| Dopaminergic_Neurons["/Dopaminergic Neurons/"]
    CELLULAR_SENESCENCE -->|"mediates"| Senescence_Associated_Secretom["Senescence-Associated Secretome"]
    CELLULAR_SENESCENCE -->|"involved_in"| Biological_Aging["Biological Aging"]
    CELLULAR_SENESCENCE -->|"contributes to"| Aging["Aging"]
    Lipid_Accumulation["Lipid Accumulation"] -->|"causes"| CELLULAR_SENESCENCE
    AMPK([AMPK]) -->|"regulates"| CELLULAR_SENESCENCE
    LIPID_ACCUMULATION["LIPID ACCUMULATION"] -->|"causes"| CELLULAR_SENESCENCE
    Telomere_Dysfunction["Telomere Dysfunction"] -->|"causes"| CELLULAR_SENESCENCE
    PGAM5([PGAM5]) -->|"modulates"| CELLULAR_SENESCENCE
    Mitochondrial_Dysfunction["Mitochondrial Dysfunction"] -->|"causes"| CELLULAR_SENESCENCE
    P53([P53]) -->|"promotes"| CELLULAR_SENESCENCE
    cGAS_STING["cGAS/STING"] -->|"regulates"| CELLULAR_SENESCENCE
    cGAS_STING_signaling_pathway["cGAS/STING signaling pathway"] -->|"regulates"| CELLULAR_SENESCENCE
    Ginkgetin{"Ginkgetin"} -.->|"prevents"| CELLULAR_SENESCENCE

Outgoing (88)

Target	Relation	Type	Str
Cell Cycle Arrest	causes	phenotype	0.95
Alzheimer Disease	contributes_to	disease	0.95
cell cycle arrest	causes	phenotype	0.95
pro-inflammatory molecules	promotes	pathway	0.95
Inflammation	promotes	process	0.95
senescence-associated secretory phenotype	drives	phenotype	0.95
ALZHEIMER'S DISEASE	causes	disease	0.95
PARKINSON'S DISEASE	causes	disease	0.95
Alzheimer'S Disease	contributes_to	disease	0.95
DOPAMINERGIC NEURONS	associated_with	entity	0.95
Apoptosis Resistance	causes	phenotype	0.95
Cardiac Aging	involved_in	process	0.95
aging	associated_with	process	0.95
Senescence-Associated Secretory Phenotype	causes	phenotype	0.95
Alzheimer's Disease	contributes_to	disease	0.95
Neurodegeneration	associated_with	disease	0.95
Alzheimer'S Disease Pathology	mediates	mechanism	0.92
Neuroinflammation	promotes	process	0.90
Dopaminergic Neurons	expressed_in	cell_type	0.90
Senescence-Associated Secretory Phenotype	associated_with	phenotype	0.90
Aging	associated_with	process	0.90
senescence-related disorders	causes	disease	0.90
neurodegenerative disorders	contributes_to	disease	0.90
Senescence Biomarkers	biomarker_for	biomarker	0.90
Biological Aging	involved_in	process	0.90
Chronic Inflammation	contributes_to	process	0.90
Embryonic Development	involved_in	process	0.90
Wound Healing	involved_in	process	0.90
Obesity	associated_with	disease	0.90
Inflammation	causes	process	0.90
Neurodegenerative Diseases	contributes_to	disease	0.90
growth arrest	causes	phenotype	0.90
Inflammaging	associated_with	process	0.90
Neuroinflammation	contributes_to	process	0.90
Senescence-Associated Secretome	mediates	pathway	0.90
Cellular Dysfunction	contributes_to	phenotype	0.90
Chronic Aging-Related Diseases	contributes_to	disease	0.90
NEURODEGENERATION	contributes_to	process	0.90
AGING	associated_with	process	0.90
Biological Aging	mediates	process	0.90
Senescence-Associated Secretory Phenotype	mediates	phenotype	0.90
Cognitive Deficits	causes	phenotype	0.88
Osteoarthritis	contributes_to	disease	0.88
Myocardial Ischemia And Infarction	involved_in	disease	0.87
ASTROCYTES	expressed_in	cell_type	0.85
Brain Aging	involved_in	process	0.85
Neurodegenerative Disease	associated_with	disease	0.85
NEURON	expressed_in	cell_type	0.85
Apoptosis	associated_with	process	0.85
neurodegeneration	promotes	disease	0.85

Incoming (237)

Source	Relation	Type	Str
aging	drives	process	0.95
Alzheimer'S Disease	associated_with	disease	0.95
P53	promotes	protein	0.95
Quercetin	inhibits	compound	0.95
Dasatinib	inhibits	drug	0.95
Ginkgetin	associated_with	compound	0.95
AMPK	regulates	protein	0.95
MIR-302B	associated_with	gene	0.95
Mir-302B	associated_with	biomarker	0.95
Cgas/Sting Signaling	regulates	pathway	0.95
Ginkgetin	inhibits	compound	0.95
cGAS/STING signaling pathway	regulates	pathway	0.95
Lipid Accumulation	promotes	process	0.95
PGAM5	modulates	protein	0.95
LIPID ACCUMULATION	causes	entity	0.95
Mitochondrial Dysfunction	causes	process	0.95
Lipid Accumulation	causes	process	0.95
cGAS/STING	regulates	pathway	0.95
Telomere Dysfunction	causes	mechanism	0.95
SRT2104	suppresses	drug	0.93
Ginkgetin	prevents	drug	0.92
STING	regulates	protein	0.92
41101499	is a hallmark of	paper	0.90
SIRT1	regulates	gene	0.90
Prediabetes	associated_with	disease	0.90
mitophagy	protects_against	process	0.90
41101499	delay	paper	0.90
41101499	drives	paper	0.90
MTOR	involved_in	gene	0.90
oncogene-induced stress	causes	process	0.90
Astrocytes	involved_in	cell_type	0.90
H₂O₂	causes	compound	0.90
37679434	contributes to	paper	0.90
Microglia	involved_in	cell_type	0.90
CDKN2A	associated_with	protein	0.90
BHB	suppresses	compound	0.90
autophagy	suppresses	process	0.90
CDKN1A	associated_with	protein	0.90
Metabolic Reprogramming	associated_with	process	0.90
Intermittent Fasting	modulates	drug	0.90
Partial Reprogramming	associated_with	process	0.90
Lysosomal Impairment	associated_with	process	0.90
SDA-2026-04-01-gap-013	investigates	analysis	0.90
iPSC Reprogramming	associated_with	process	0.90
SQSTM1	prevents	gene	0.90
senolytics	targets	drug	0.90
apoptosis resistance	associated_with	phenotype	0.90
p16INK4A	regulates	protein	0.90
IL23R	biomarker_for	protein	0.90
Glucocerebrosides	causes	compound	0.90

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Closed-loop neuromodulation-inspired cytokine axis suppressi	0.530	cell-biology	-
P2RY12 activation induces cellular senescence in cerebral VS	0.373	neurodegeneration	How does P2RY12-mediated VSMC dysfunctio

Mentioning Analyses (8)

Scientific analyses that reference this entity

TREM2 in Alzheimer's Disease: Mechanisms, Therapeutics, and Biomarkers

neurodegeneration | 2026-04-26 | 8 hypotheses Top: 0.861

Can P16INK4A expression reliably distinguish harmful from beneficial senescent m

neurodegeneration | 2026-04-11 | 0 hypotheses

Do APOE4-driven senescent astrocytes cause neurodegeneration or represent a prot

neurodegeneration | 2026-04-06 | 7 hypotheses Top: 0.720

How do regional, age, and sex-dependent differences in microglial populations af

neuroinflammation | 2026-04-06 | 7 hypotheses Top: 0.721

Senescent cell clearance as neurodegeneration therapy

neurodegeneration | 2026-04-04 | 7 hypotheses Top: 0.769

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (19)

Multi-agent debates referencing this entity

Extended debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Extended debate: TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegenera

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Hypothesis debate: TREM2-Mediated Microglial Dysfunction Disrupts Perivascular T

closed · Rounds: 4 · Score: 0.50 · 2026-04-27

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.44 · 2026-04-27

Hypothesis debate: TREM2-Dependent Microglial Senescence Transition

closed · Rounds: 4 · Score: 0.64 · 2026-04-26

Hypothesis debate: SASP Modulation Rather Than Cell Elimination

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegene

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

What are the key mechanistic, therapeutic, and diagnostic dimensions of TREM2 in

closed · Rounds: 4 · Score: 0.92 · 2026-04-26

Related Research

Hypotheses and analyses mentioning CELLULAR SENESCENCE in their description or question text

No additional research found

CELLULAR SENESCENCE

Understanding Entity Pages

Pathway Diagram

Outgoing (88)

Incoming (237)

Targeting Hypotheses (2)

Mentioning Analyses (8)

TREM2 in Alzheimer's Disease: Mechanisms, Therapeutics, and Biomarkers

Can P16INK4A expression reliably distinguish harmful from beneficial senescent m

Do APOE4-driven senescent astrocytes cause neurodegeneration or represent a prot

How do regional, age, and sex-dependent differences in microglial populations af

Senescent cell clearance as neurodegeneration therapy

Gene expression changes in aging mouse brain predicting neurodegenerative vulner

Senescent cell clearance as neurodegeneration therapy

Epigenetic clocks and biological aging in neurodegeneration

Experiments (0)

Related Papers (0)

Debates (19)

Extended debate: Metabolic Reprogramming to Reverse Senescence

Extended debate: TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegenera

Hypothesis debate: TREM2-Mediated Microglial Dysfunction Disrupts Perivascular T

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

Hypothesis debate: TREM2-Dependent Microglial Senescence Transition

Hypothesis debate: SASP Modulation Rather Than Cell Elimination

Hypothesis debate: TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegene

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

What are the key mechanistic, therapeutic, and diagnostic dimensions of TREM2 in

Related Research